232 related articles for article (PubMed ID: 17987073)
21. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.
Roncucci L; Mora E; Mariani F; Bursi S; Pezzi A; Rossi G; Pedroni M; Luppi D; Santoro L; Monni S; Manenti A; Bertani A; Merighi A; Benatti P; Di Gregorio C; de Leon PM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2291-7. PubMed ID: 18768495
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers in colorectal cancer.
Owen RW
IARC Sci Publ; 2001; 154():101-11. PubMed ID: 11220650
[TBL] [Abstract][Full Text] [Related]
23. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
24. RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.
Subramaniam MM; Chan JY; Soong R; Ito K; Yeoh KG; Wong R; Guenther T; Will O; Chen CL; Kumarasinghe MP; Ito Y; Salto-Tellez M
Am J Gastroenterol; 2009 Feb; 104(2):426-36. PubMed ID: 19174785
[TBL] [Abstract][Full Text] [Related]
25. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
26. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management.
East JE; Saunders BP; Jass JR
Gastroenterol Clin North Am; 2008 Mar; 37(1):25-46, v. PubMed ID: 18313538
[TBL] [Abstract][Full Text] [Related]
27. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
Gupta AK; Schoen RE
Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
[TBL] [Abstract][Full Text] [Related]
28. Endoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma.
Søreide K; Nedrebø BS; Reite A; Thorsen K; Kørner H
Expert Rev Mol Diagn; 2009 Mar; 9(2):125-37. PubMed ID: 19298137
[TBL] [Abstract][Full Text] [Related]
29. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept.
Snover DC; Jass JR; Fenoglio-Preiser C; Batts KP
Am J Clin Pathol; 2005 Sep; 124(3):380-91. PubMed ID: 16191506
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnostics in colorectal carcinoma.
Bhalla A; Zulfiqar M; Weindel M; Shidham VB
Clin Lab Med; 2013 Dec; 33(4):835-59. PubMed ID: 24267189
[TBL] [Abstract][Full Text] [Related]
31. Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
Huan Z; Nakayama K; Nakayama N; Ishibashi M; Yeasmin S; Katagiri A; Purwana IN; Iida K; Maruyama R; Fukumoto M; Miyazaki K
Oncol Rep; 2008 Mar; 19(3):775-81. PubMed ID: 18288415
[TBL] [Abstract][Full Text] [Related]
32. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
33. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
[TBL] [Abstract][Full Text] [Related]
35. [Sessile serrated polyps of the colorectum: how to distinguish a sessile serrated adenoma from a hyperplastic polyp in a daily practice?].
Sandmeier D; Bouzourene H
Ann Pathol; 2008 Apr; 28(2):79-84. PubMed ID: 18675157
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome profile of human colorectal adenomas.
Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
[TBL] [Abstract][Full Text] [Related]
37. Molecular stool screening for colorectal cancer.
Mak T; Lalloo F; Evans DG; Hill J
Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
[TBL] [Abstract][Full Text] [Related]
38. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
39. [Colorectal carcinogenesis. Tumor-associated antigens and aneuploidy even in adenomas].
Fischbach W
Fortschr Med; 1991 Jan; 109(2):55-6. PubMed ID: 2026370
[No Abstract] [Full Text] [Related]
40. [Lectin receptors--markers of colorectal adenomatous dysplasia].
Dejica D; Vierbuchen M; Uhlenbruck G; Fischer R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):245-52. PubMed ID: 2904164
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
